Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Phibro Animal Health Corporation Reports Second Quarter Results
February 6, 2019 4:25 PM ESTTEANECK, N.J., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2018.
Highlights for the December 2018 quarter (compared to the December 2017 quarter)
Net sales of $218 million, an increase of $12 million, or 6%Net income of $15 million, an increase of $8 millionDiluted EPS of $0.36, an increase of $0.19Adjusted EBITDA of $32 million, a decline of $0.9 million, or 3%Adjusted diluted EPS of $0.41, a decrease of $0.03, or 7%COMMENTARY
... More